Cable Hill Partners, LLC Dia Medica Therapeutics Inc. Transaction History

Cable Hill Partners, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 06, 2019	SELL	$2.7 - $4.96 $2,700 - $4,960	-1,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$3.1 - $4.54 $3,100 - $4,540	1,000 New	1,000 $5,000

4.22M

8.2K

200

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $138M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.